Ultrasound-guided pacemaker lead placement to prevent valve leak
Part of Heart & circulation clinical trials.
This trial tests a way to place a pacemaker lead using a special ultrasound view through the esophagus (a transesophageal echocardiogram). The goal is to reduce the chance of developing a serious leak in the tricuspid valve caused by the pacemaker lead.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need a pacemaker lead that goes into the right ventricle, based on standard guidelines
- You do not already have a tricuspid valve leak that is moderate to severe (grade 2 or higher)
- You do not have other severe problems with heart valves
- You have not had prior treatment on the tricuspid valve
- You do not already have a right-ventricle pacemaker lead
- You are able to safely have the ultrasound test done through the esophagus
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how heart devices like pacemakers affect the tricuspid valve over time. It uses ultrasound to check valve function and see if the device causes any problems.
This trial tests a catheter-based procedure (done through the blood vessels) to repair a severely leaky tricuspid valve. It may help people with symptoms or past hospitalizations from tricuspid valve leakage who are higher-risk for standard surgery.
This trial tests a procedure that uses a small clip to fix a leaky tricuspid valve in the heart. The goal is to reduce symptoms like shortness of breath and fatigue, and help you feel better in your daily life.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This trial uses safe, non-invasive tests to study people with moderate or severe tricuspid regurgitation (leaky valve on the right side of the heart). It aims to better understand the condition, which may lead to improved care in the future.
This trial studies a catheter-based repair to help fix a leaky tricuspid valve (regurgitation), especially when you’re also having another heart surgery. It aims to improve valve function and symptoms while tracking safety and outcomes.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.